Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Meals, Microbiota and Mental Health in Children and Adolescents (MMM-Study): A protocol for an observational longitudinal case-control study.
Asbjornsdottir B, Lauth B, Fasano A, Thorsdottir I, Karlsdottir I, Gudmundsson LS, Gottfredsson M, Smarason O, Sigurdardottir S, Halldorsson TI, Marteinsson VT, Gudmundsdottir V, Birgisdottir BE. Asbjornsdottir B, et al. PLoS One. 2022 Sep 1;17(9):e0273855. doi: 10.1371/journal.pone.0273855. eCollection 2022. PLoS One. 2022. PMID: 36048886 Free PMC article.
Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4.
Bajaj HS, Ásbjörnsdóttir B, Carstensen L, Laugesen C, Mathieu C, Philis-Tsimikas A, Battelino T. Bajaj HS, et al. Among authors: asbjornsdottir b. Diabetes Care. 2024 Apr 1;47(4):729-738. doi: 10.2337/dc23-2136. Diabetes Care. 2024. PMID: 38380954 Free PMC article. Clinical Trial.
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial.
Mathieu C, Ásbjörnsdóttir B, Bajaj HS, Lane W, Matos ALSA, Murthy S, Stachlewska K, Rosenstock J. Mathieu C, et al. Among authors: asbjornsdottir b. Lancet. 2023 Jun 10;401(10392):1929-1940. doi: 10.1016/S0140-6736(23)00520-2. Epub 2023 May 5. Lancet. 2023. PMID: 37156252 Clinical Trial.
Thirty novel sequence variants impacting human intracranial volume.
Nawaz MS, Einarsson G, Bustamante M, Gisladottir RS, Walters GB, Jonsdottir GA, Skuladottir AT, Bjornsdottir G, Magnusson SH, Asbjornsdottir B, Unnsteinsdottir U, Sigurdsson E, Jonsson PV, Palmadottir VK, Gudjonsson SA, Halldorsson GH, Ferkingstad E, Jonsdottir I, Thorleifsson G, Holm H, Thorsteinsdottir U, Sulem P, Gudbjartsson DF, Stefansson H, Thorgeirsson TE, Ulfarsson MO, Stefansson K. Nawaz MS, et al. Among authors: asbjornsdottir b. Brain Commun. 2022 Oct 25;4(6):fcac271. doi: 10.1093/braincomms/fcac271. eCollection 2022. Brain Commun. 2022. PMID: 36415660 Free PMC article.
Episodic ataxia type 2 (EA2) with interictal myokymia and focal dystonia.
Nielsen EN, Ásbjörnsdóttir B, Møller LB, Nielsen JE, Lindquist SG. Nielsen EN, et al. Among authors: asbjornsdottir b. Cold Spring Harb Mol Case Stud. 2022 Oct 28;8(6):a006236. doi: 10.1101/mcs.a006236. Print 2022 Oct. Cold Spring Harb Mol Case Stud. 2022. PMID: 36307210 Free PMC article.
32 results